Written Question·Department of Health and Social Care·UIN HL15195

Orphan Drugs

Tabled: 4 March 2026
Answered: 11 March 2026

Question

To ask His Majesty's Government what assessment they have made of the recommendation in the report by the UK BioIndustry Association From innovation to impact: unlocking patient access to innovative rare disease medicines, published on 4 December 2025, to

Answer

There are no plans to introduce a separate evaluation process for orphan medicines. Most medicines, including orphan medicines, are assessed through the National Institute for Health and Care Excellence’s (NICE) standard technology appraisal programme, wi...
ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN HL15195) →